{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:44:05Z","timestamp":1773287045486,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000102","name":"Health Resources and Services Administration","doi-asserted-by":"publisher","award":["T0BHP28581"],"award-info":[{"award-number":["T0BHP28581"]}],"id":[{"id":"10.13039\/100000102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the National Medical Association"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jnma.2020.11.012","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T17:02:26Z","timestamp":1608224546000},"page":"297-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Critical Race Theory as a Lens for Examining Primary Care Provider Responses to Persistently-Elevated HbA1c"],"prefix":"10.1016","volume":"113","author":[{"given":"Amy","family":"Cunningham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denine","family":"Crittendon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Konys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Casola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Arenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jnma.2020.11.012_bib1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s12325-018-0819-5","article-title":"Addressing clinical inertia in type 2 diabetes mellitus: a review","volume":"35","author":"Okemah","year":"2018","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.jnma.2020.11.012_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.diabres.2014.05.005","article-title":"Time to do more: addressing clinical inertia in the management of type 2 diabetes mellitus","volume":"105","author":"Strain","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jnma.2020.11.012_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pharmtox-010716-104952","article-title":"Changing provider behavior in the context of chronic disease management: focus on clinical inertia","volume":"57","author":"Lavoie","year":"2017","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"10.1016\/j.jnma.2020.11.012_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.diabet.2017.06.003","article-title":"Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus","volume":"43","author":"Reach","year":"2017","journal-title":"Diabete Metab"},{"key":"10.1016\/j.jnma.2020.11.012_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819844694","article-title":"Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia","volume":"10","author":"Khunti","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.jnma.2020.11.012_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/dme.12592","article-title":"Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study","volume":"32","author":"Zafar","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jnma.2020.11.012_bib7","series-title":"Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care","author":"Nelson","year":"2003"},{"issue":"4","key":"10.1016\/j.jnma.2020.11.012_bib8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.amjms.2016.01.008","article-title":"Influence of race, ethnicity and social determinants of health on diabetes outcomes","volume":"351","author":"Walker","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jnma.2020.11.012_bib9","first-page":"1","article-title":"Racial\/ethnic disparities in diabetes quality of care: the role of healthcare access and socioeconomic status","author":"Canedo","year":"2017","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"issue":"6","key":"10.1016\/j.jnma.2020.11.012_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1525-1497.2002.10633.x","article-title":"Designing and evaluating interventions to eliminate racial and ethnic disparities in health care","volume":"17","author":"Cooper","year":"2002","journal-title":"J\u00a0Gen Intern Med"},{"issue":"8","key":"10.1016\/j.jnma.2020.11.012_bib11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.90.8.1212","article-title":"Levels of racism: a theoretic framework and a gardener's tale","volume":"90","author":"Jones","year":"2000","journal-title":"Am J Public Health"},{"issue":"22","key":"10.1016\/j.jnma.2020.11.012_bib12","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMp1609535","article-title":"Structural racism and supporting black lives-the role of health professionals","volume":"375","author":"Hardeman","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"S1","key":"10.1016\/j.jnma.2020.11.012_bib13","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.2105\/AJPH.2009.171058","article-title":"Critical race theory, race equity, and public health: toward antiracism praxis","volume":"100","author":"Ford","year":"2010","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.jnma.2020.11.012_bib14","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1370\/afm.679","article-title":"Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin","volume":"5","author":"Parchman","year":"2007","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.jnma.2020.11.012_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc20-Sint","article-title":"Standards of medical care in diabetes 2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jnma.2020.11.012_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3352\/jeehp.2013.10.12","article-title":"The retrospective chart review: important methodological considerations","volume":"10","author":"Vassar","year":"2013","journal-title":"J\u00a0Educ Eval Health Prof"},{"issue":"11","key":"10.1016\/j.jnma.2020.11.012_bib17","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1001\/archinte.168.11.1145","article-title":"Physician performance and racial disparities in diabetes mellitus care","volume":"168","author":"Sequist","year":"2008","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.jnma.2020.11.012_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/ACM.0000000000001810","article-title":"A\u00a0call for critical race theory in medical education","volume":"92","author":"Tsai","year":"2017","journal-title":"Acad Med"}],"container-title":["Journal of the National Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968420304314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0027968420304314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:18:24Z","timestamp":1758435504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0027968420304314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0027968420304314"],"URL":"https:\/\/doi.org\/10.1016\/j.jnma.2020.11.012","relation":{},"ISSN":["0027-9684"],"issn-type":[{"value":"0027-9684","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Critical Race Theory as a Lens for Examining Primary Care Provider Responses to Persistently-Elevated HbA1c","name":"articletitle","label":"Article Title"},{"value":"Journal of the National Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnma.2020.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the National Medical Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}